Genetic risk of disease development among HTLV-I carriers

Gann Monographs on Cancer Research

Volumn 50, Issue , 2003, Pages 289-301

  Sonoda, Shunro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; SYNTHETIC PEPTIDE; TAX PROTEIN; VIRUS ENVELOPE PROTEIN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN BINDING; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE FREQUENCY; GENE SEGREGATION; GENETIC PREDISPOSITION; GENETIC RISK; HETEROZYGOTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 ASSOCIATED MYELOPATHY; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN MOTIF; SEQUENCE ANALYSIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; VIRUS CARRIER;

EID: 24644503135     PISSN: 00720151     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (35)

1. Cabrera, M. E. et al. HTLV-I positive adult T-cell leukemia/lymphoma (ATLL) in Chile. Leukemia, 8, 1763-1767 (1994).
2. Cartier, L. et al. HTLV-I positive spastic paraparesis in a temperate zone. Lancet, i, 556-557 (1989).
3. Clerici, M., Lucey, D. R., Zajac, R. A. et al. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol., 146, 2214-2219 (1991).
4. Davenport, M. P. and Hill, A. V. Reverse immunogenetics: from HLA-disease association to vaccine candidates. Mol. Med. Today, 2, 38-45 (1996).
5. + T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc. Natl. Acad. Sci. USA, 95, 3111-3116 (1998).
6. Gotch, F. M., Nixon, D. F., Alp, N., McMichael, A. J., and Borysiewicz, L. K. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV sero-positive individuals. Int. Immunol., 2, 707-712 (1990).
7. Goulder, P., Conlon, C., McIntyre, K., and McMichael, A. Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag. AIDS, 10, 1441-1443 (1996).
8. Haniwara, K. Origin and affinities of Japanese viewed from cranial measurements. Acta Anthropogenet., 8, 149-158 (1984).
9. Ishida, T. and Hinuma, Y. The origin of Japanese HTLV-I. Nature, 322, 564 (1986).
10. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature, 348, 245-248 (1990).
11. + human T lymphotropic virus type-I-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunologic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-I. J Immunol., 146, 1155-1162 (1991).
12. Jeffery, K. J. et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl Acad. Sci. USA, 96, 3848-3853 (1999).
13. + cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol., 3, 761-767 (1991).
14. Katahira, Y., Yashiki, S., Fujiyoshi, T., Nomura, K., Tara, M., Mori, M., Setoyama, M., Kanzaki, T., Shida, H., and Sonoda, S. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn. J. Cancer Res., 86, 21-27 (1995).
15. Kayembe, K. et al. A cluster of HTLV-I-associated tropical spastic paraparesis in Equateur (Zaire); ethnic and familial distribution. J. Neurol. Neurosurg. Psychiatry, 53, 4-10 (1990).
16. Nagai, M., Yashiki, S., Fujiyoshi, T. et al. Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. J. Neuroimmunol., 65, 97-105 (1996).
17. Nelson, G. W., Kaslow, R., and Mann, D. L. Frequency of HLA allele-specific peptide motifs in HIV-I proteins correlates with the alleles association with relative rates of disease progression after HIV-I infection. Proc. Natl. Acad. Sci. USA, 94, 9802-9807 (1997).
18. Osame, M. et al. HTLV-I-associated myelopathy (HAM), treatment trials, retrospective survey and clinical laboratory findings. Hematol. Rev., 3, 271-284 (1990).
19. Osame, M. et al. Nationwide survey of HTLV-I-associated myelopathy in Japan; association with blood transfusion. Ann. Neurol., 28, 51-56 (1990).
20. Parker, C. E., Nightingale, S., Taylor, G. P., Weber, J., and Bangham, C. R. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol., 68, 2860-2868 (1994).
21. Rammensee, H. G., Friede, T., and Stevanoviic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228 (1995).
22. Shaw, G. et al. Human T-cell leukemia virus; its discovery and role in leukemogenesis and immunosuppression. Adv. Intern. Med., 30, 1-27 (1984).
23. Shoji, H. et al. HTLV-I-associated myelopathy and adult T-cell leukemia cases in a family. Eur. J. Neurol., 29, 33-35 (1989).
24. Sonoda, S., Fujiyoshi, T., and Yashiki, S. Immunogenetics of HTLV-I/II and associated diseases. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 13 (Suppl. 1), S119-S123 (1996).
25. Sonoda, S., Yashiki, S., Fujiyoshi, T. et al. Immunogenetic factors involved in the pathogenesis of adult T-cell leukemia and HTLV-I-associated myelopathy. In "Advances in Adult T-cell Leukemia and HTLV-I Research," ed. S. Takatsuki, Y. Hinuma, and M. Yoshida, Gann Monograph on Cancer Research No. 39, pp. 81-93 (1992). Japan Sci. Soc. Press, Tokyo.
26. Sonoda, S. et al. Immunogenetics of HTLV-I/II and associated diseases. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 13, S119-S123 (1996).
27. Tajima, K. HTLV-I/II related disease with special reference to its distribution among mongoloids. In "Ethnoepidemiology of Cancer," ed. K. Tajima and S. Sonoda, Gann Monograph on Cancer Research No. 44, pp. 123-135 (1996). Japan Sci. Soc. Press, Tokyo.
28. Tajima, K. and the T- and B-cell Malignancy Study Group. The 4th nationwide study of adult T-cell leukemia/lymphoma (ATL) in Japan; estimation of risk of ATL and its geographical and clinical features. Int. J. Cancer, 45, 237-243 (1990).
29. Tendler, C. L., Greenberg, S. J., Blattner, W. A. et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA, 87, 5218-5222 (1990).
30. Tomiyama, H., Miwa, K., Shiga, H. et al. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J. Immunol., 158, 5026-5034 (1997).
31. Usuku, K., Sonoda, S., Osame, M. et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol., 23 (Suppl. 1), S143-S150 (1988).
32. Walker, B. D., Flexner, C., Paradis, T. J. et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science, 240, 64-66 (1988).
33. + cytotoxic T lymphocytes. AIDS Res. Hum. Retroviruses, 17, 1047-1061 (2001).
34. Yoshida, M., Osame, M., Kawai, H. et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol., 26, 331-335 (1989).
35. Yoshida, M., Osame, M., Usuku, K., Matsumoto, M., and Igata, A. Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting. Lancet, i, 1085-1086 (1987).